aTyr Pharma, Inc.
ATYR
$4.04
$0.051.25%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.26M | -16.31M | -15.49M | -14.76M | -11.34M |
| Total Depreciation and Amortization | 388.00K | 383.00K | 770.00K | 407.00K | 993.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 141.00K | -8.00K | -67.00K | -228.00K | -315.00K |
| Change in Net Operating Assets | 3.57M | -4.52M | -7.59M | 3.52M | 1.10M |
| Cash from Operations | -13.16M | -20.45M | -22.38M | -11.06M | -9.56M |
| Capital Expenditure | -15.00K | -8.00K | -17.00K | -17.00K | -557.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.96M | 6.74M | -1.34M | 17.84M | 4.94M |
| Cash from Investing | 17.95M | 6.73M | -1.36M | 17.82M | 4.38M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -125.00K | -123.00K | -121.00K | -115.00K | -108.00K |
| Issuance of Common Stock | 20.00K | 13.52M | 7.85M | 6.15M | 2.79M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.00K | 13.40M | 7.73M | 6.03M | 2.68M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.68M | -321.00K | -16.01M | 12.79M | -2.49M |
